Discover
GANX
Gain Therapeutics, Inc.
1.99
2 x 1.51
2 x 2.48
bid
ask
-
0.04
1.97%
2 @ 04:39 AM
1.95 -0.04 (2.01%)
| Ytd | -38.20% | |
| 1y | 26.75% |
1.92
day range
2.15
1.41
52 week range
4.34
| Open | 2.02 | Prev Close | 2.03 | Low | 1.92 | High | 2.15 | Mkt Cap | 84.88M |
| Vol | 1.49M | Avg Vol | 843.50K | EPS | -0.58 | P/E | N/A | Forward P/E | -1.76 |
| Beta | 0.34 | Short Ratio | 1.65 | Inst. Own | 7.96% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-11 | 50-d Avg | 1.82 | 200-d Avg | 2.20 | 1yr Est | 7.33 |
| Income Statement | |||
| Operating Expenses | 5.35M | ||
| Research and Development Expense | 2.76M | ||
| Selling, General and Administrative Expense | 2.59M | ||
| Operating Income | -5.35M | ||
| Income Tax Expense | 183.07K | ||
| Net Income | -5.61M | ||
| Net Income Common Stock | -5.61M | ||
| Net Income Common Stock (USD) | -5.61M | ||
| Consolidated Income | -5.61M | ||
| Earnings per Basic Share | -0.13 | ||
| Earnings per Basic Share (USD) | -0.13 | ||
| Earnings per Diluted Share | -0.13 | ||
| Earning Before Interest & Taxes (EBIT) | -5.43M | ||
| Earning Before Interest & Taxes (USD) | -5.43M | ||
| Weighted Average Shares | 42.23M | ||
| Weighted Average Shares Diluted | 42.23M | ||
| Balance Sheet | |||
| Cash and Equivalents | 16.54M | ||
| Cash and Equivalents (USD) | 16.54M | ||
| Investments | 36.09K | ||
| Investments Non-Current | 36.09K | ||
| Current Assets | 18.22M | ||
| Property, Plant & Equipment Net | 355.01K | ||
| Total Assets | 18.74M | ||
| Debt Current | 216.91K | ||
| Total Debt | 672.30K | ||
| Current Liabilities | 3.89M | ||
| Debt Non-Current | 455.39K | ||
| Total Liabilities | 4.73M | ||
| Accumulated Retained Earnings (Deficit) | -106.96M | ||
| Accumulated Other Comprehensive Income | 996.95K | ||
| Shareholders Equity | 14.01M | ||
| Shareholders Equity (USD) | 14.01M | ||
| Assets Non-Current | 516.70K | ||
| Total Debt (USD) | 672.30K | ||
| Goodwill and Intangible Assets | 90.05K | ||
| Liabilities Non-Current | 844.91K | ||
| Trade and Non-Trade Payables | 1.52M | ||
| Tax Assets | 231.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 21.30K | ||
| Net Cash Flow from Financing | 404.32K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -4.30M | ||
| Issuance (Purchase) of Equity Shares | 429.85K | ||
| Issuance (Repayment) of Debt Securities | -25.52K | ||
| Net Cash Flow from Operations | -4.73M | ||
| Effect of Exchange Rate Changes on Cash | 24.59K | ||
| Share Based Compensation | 403.51K | ||